Basaglar KwikPen

Basaglar KwikPen is an FDA-approved prescription long-acting insulin pen used to manage blood sugar levels in people with diabetes mellitus. It contains insulin Glargine, which is a synthetic form of insulin. The Basaglar KwikPen is available in the form of a prefilled 3 ml injectable pen, which is designed for subcutaneous use only. Basaglar is contraindicated for use in people with Hypoglycemia and a history of hypersensitivity to glargine or any of the inactive ingredients found in Basaglar KwikPen. You should consult your doctor in case of any query or concern regarding the prescription.

The Basaglar KwikPen is an FDA-approved long-acting insulin pen containing insulin glargine, a synthetic form of insulin. The prescription injection is used to manage blood sugar levels in individuals with type 1 and type 2 diabetes. Insulin glargine works by providing a steady release of insulin over an extended period, helping to maintain consistent blood sugar levels throughout the day.

The Basaglar KwikPen is available in a prefilled 3ml delivery device, with dosages ranging from 1 to 80 units. It is typically administered once daily at a consistent time, with the dosage determined by the individual’s needs and response to treatment. The pen is designed for subcutaneous injections and should be used as directed by a healthcare provider.

Common side effects of the Basaglar KwikPen include hypoglycemia, injection site reactions, and weight gain. It is essential to monitor blood sugar levels regularly and adjust the Basaglar KwikPen dosage as needed under the guidance of a healthcare professional. In case of a missed dose or overdose, consult a healthcare provider immediately. The pen should be stored at room temperature and used within 28 days of opening. Always follow the instructions for proper usage, dosage, and storage of the Basaglar KwikPen.

It is used in adults and children above the age of 6 with:

• Type 1 diabetes
• Type 2 diabetes

Dosage

Basaglar KwikPen comes in the form of a pre-filled injectable pen that has the following strengths:

• 100 units of insulin glargine/ ml

What Are the Recommended Basaglar KwikPen Dosages for Different Patients?

For Patients with Type 1 Diabetes

• Initial Dose: One-third of your total insulin dosage. The total insulin dosage is based on your body weight (in kg).
• The dose ranges from 0.4 units/kg to 1 unit/kg daily. Talk with your doctor to know the correct dose for your condition.

For Patients with Type 2 Diabetes

• Initial Dose: 0.2 units of insulin per kg of your body weight. 
• Maximum Initial Dose: 10 units of Basaglar daily.

For Pediatric Patients

• Initial Dose:The initial dosage for children with diabetes (not type 2) is the same as for adults.
• The starting dosage is about one-third of the total insulin dosage.
• The total dosage is based on the child’s weight (in kg). The dose ranges from 0.4 units/kg to 1 unit/kg daily.

[Note: Remember these recommendations may vary depending on person to person. Discuss it with your doctor, and they’ll customize your dosage accordingly.]

Follow these steps to inject these pens safely:

• Properly wash your hands before injecting the insulin.
• Roll the insulin bottle and wipe the bottle up.
• Pull the syringe plunger down to the number of units prescribed by your doctor.
• Push the needle into the bottle and push the syringe plunger down.
• Again, pull the plunger down to the number of units prescribed.
• Choose the injection spot and clean it with an alcohol swab or soap and water. Always rotate the injection spot to avoid injection site reactions.
• Pinch up the skin, push the Basaglar KwikPen needles into the skin and then push the plunger in.
• To make sure that the entire dose has been injected, keep the needle under the skin for at least 6 seconds.
• After successfully injecting the insulin, dispose of the needle and syringe safely in a sharp disposal container.

[Note: Your doctor will decide the right amount for you based on your condition, following guidelines and studies on the drug. They’ll adjust it as needed over time.]

Basaglar KwikPen contains a long-acting type of insulin that starts to work after several hours of injection and keeps working evenly for 24 hours. It is used to treat diabetes mellitus in adults and children not younger than 6 years with type 1 diabetes and adults with type 2 diabetes. It works like human insulin and helps glucose enter the cells so your body can use it for energy. It also reduces the production of sugar in the liver.

Common Side Effects of Basaglar KwikPen: Basaglar KwikPen, an insulin glargine injection used to manage blood sugar levels in differently aged people with diabetes, can cause several side effects. This includes:

• Hypoglycemia: Basaglar KwikPen can cause hypoglycemia, a condition characterized by abnormally low blood sugar levels. Hypoglycemia is one of the most common side effects of Basaglar KwikPen and can be serious if not managed properly. Symptoms of hypoglycemia may include shaking, dizziness, sweating, confusion, and, in very serious cases, loss of consciousness. It is important for patients using Basaglar KwikPen to monitor their sugar levels regularly and to have a plan in place to treat hypoglycemia quickly, such as consuming fast-acting carbohydrates like glucose tablets or juice.
• Injection Site Reactions: These reactions are a common side effect of using Basaglar KwikPen. These reactions may include redness, swelling, itching, or pain at the site where the insulin is injected. While these reactions are generally mild & resolve on their own, they can be uncomfortable for the patient. To minimize the chance or risk of injection site reactions, it is highly recommended to rotate injection sites regularly and to avoid injecting into areas that are already irritated or swollen. If the reactions persist or worsen, it is very important to consult a healthcare professional.
• Hypersensitivity Reactions: Basaglar KwikPen may cause hypersensitivity reactions in some individuals. These reactions range from mild to severe & can have symptoms such as rash, itching, or hives. In rare cases, more severe hypersensitivity reactions, such as anaphylaxis, can occur. It is important for patients to be aware of the signs of a hypersensitivity reaction and to seek medical attention immediately if they experience any symptoms after using Basaglar KwikPen. Patients with a known allergy to insulin glargine or any of the components of Basaglar KwikPen should avoid using this medication.
• Lipodystrophy: Lipodystrophy is a potential side effect of Basaglar KwikPen, characterized by changes in the fatty tissue at the site of insulin injection. This condition can cause either lipoatrophy (loss of fat tissue) or lipohypertrophy (accumulation of fat tissue). Lipodystrophy can affect the absorption of insulin, leading to fluctuations in blood sugar control. To reduce the risk of developing lipodystrophy, patients are advised to rotate injection sites regularly and avoid injecting into areas with visible changes in fat tissue. If lipodystrophy develops, it is important to consult with a healthcare provider for proper management.
• Weight Gain: This is a common side effect associated with the use of Basaglar KwikPen. Insulin therapy, including Basaglar KwikPen, can lead to weight gain as it helps the body to store glucose, which can increase fat storage. Patients may notice an increase in weight as they begin insulin therapy, particularly if their blood sugar levels have been very high for an extended period. To manage weight gain while using Basaglar KwikPen, it is important to maintain a balanced diet, engage in regular physical activity, and monitor weight regularly. Consulting with a healthcare provider or doctor for personalized advice may also be beneficial.

Mild Side Effects of Basaglar KwikPen: It is a long-acting insulin that helps maintain stable blood sugar levels throughout the day. It also causes mild side effects, including:

• Changes in Vision: One of the mild side effects of Basaglar KwikPen is changes in vision. These changes might occur as the body adjusts to new blood sugar levels with the use of Basaglar KwikPen. Some individuals may experience blurred vision or temporary difficulty in focusing. These symptoms are usually mild & tend to resolve as the body adapts. However, if the changes in vision persist or worsen, it is important to consult with a doctor or healthcare provider to determine if Basaglar KwikPen is the right medication for you.
• Nausea or Vomiting: Basaglar KwikPen may cause mild nausea or vomiting as a side effect, particularly during the initial stages of treatment. This can occur as the body adjusts to changes in blood sugar levels. While these symptoms are generally temporary, it is important to monitor them closely. Drinking plenty of fluids & eating smaller, more frequent meals may help alleviate nausea. If nausea or vomiting persists or becomes severe, it is advisable to speak with a healthcare giver to ensure that Basaglar KwikPen is still suitable for your diabetes management.
• Headache: Headaches are a potential mild side effect of using Basaglar KwikPen. These headaches may occur as a result of fluctuations in sugar levels as the body adjusts to the medication. Generally, these headaches are temporary and should subside as the body becomes accustomed to Basaglar KwikPen. Over-the-counter pain relief may be used, but it is important to consult a healthcare provider if headaches persist or worsen, as this could indicate an issue with blood sugar management or an adverse reaction to Basaglar KwikPen.
• Fluid Retention or Edema: Fluid retention, or edema, is a mild side effect that can occur with the use of Basaglar KwikPen. This condition includes the buildup of excess fluid in the body’s tissues, leading to swelling, particularly in the legs, ankles, or feet. While this side effect is generally mild and may resolve on its own, persistent or worsening swelling should be evaluated by a doctor or healthcare provider. Monitoring fluid intake and discussing any changes in swelling with a healthcare provider can help manage this side effect while using Basaglar KwikPen.
• Thickening or Hollowing of the Skin: The use of Basaglar KwikPen can lead to a mild side effect where the skin at the injection site may become thickened or hollowed out, a condition known as lipodystrophy. If you notice any changes in the texture or appearance of your skin at the injection site, consult your healthcare provider to discuss possible adjustments to your injection technique while using Basaglar KwikPen.

Serious Side Effects of Basaglar KwikPen: Users of Basaglar KwikPen can suffer from these serious side effects:

• Anaphylaxis: This is a rare but serious side effect of Basaglar KwikPen. This severe allergic reaction can occur suddenly and may cause symptoms like swelling of the face or throat, difficulty breathing, and a rapid drop in blood pressure. If you experience any of these symptoms after using Basaglar KwikPen, seek emergency medical attention immediately. Anaphylaxis is a life-threatening condition, and prompt treatment is essential to prevent serious complications.
• Heart Failure: Basaglar KwikPen may increase the risk of heart failure, particularly in people with a history of heart disease. Symptoms of heart failure caused by Basaglar KwikPen include severe swelling in the legs, shortness of breath, and fatigue. These symptoms can develop gradually or suddenly, and immediate medical attention is necessary if they occur. If you have pre-existing heart conditions, inform your healthcare provider before starting Basaglar KwikPen. Regular monitoring of your heart health while using Basaglar KwikPen is crucial to detect any early signs of heart failure and manage them effectively.

[Note: This list may not cover all possible side effects. Always consult with your healthcare giver for medical advice about side effects.]

The Basaglar KwikPen comes with several warnings to ensure safe use. This includes:

• The Basaglar KwikPen can cause hypoglycemia (low blood sugar). Hypoglycemia should be recognized and managed by patients.
• During illness or stress, dose adjustments may be necessary for hyperglycemia (high blood sugar).
• Patients at risk of hypokalemia should be monitored for potassium levels.
• Allergic reactions, while rare, can occur. When you notice signs of a severe allergic reaction, seek immediate medical attention.
• In some patients, Basaglar KwikPen needles can cause fluid retention, which can exacerbate heart failure.
• Patients with hepatic or renal issues may require dose adjustments.

The Basaglar KwikPen requires specific precautions to ensure its effective use:

• You should not use a Basaglar KwikPen or tempo pen if you are allergic to insulin or if you have hypoglycemia or diabetic ketoacidosis. 
• Basaglar is not to treat children below 6 years. Do not use this medicine to treat type 2 diabetes in children. Discuss your family history and medical condition with your doctor, especially if you have heart, kidney or liver disease.
• Let your doctor know if you take any other medication in oral form to treat diabetes. Using oral diabetes medicines while using insulin may increase the risk of heart-related issues.
• Tell your doctor if you are pregnant or breastfeeding. If you’re pregnant, follow all the instructions given by your doctor. It is essential to control diabetes while you’re pregnant.

• Basalgar is contraindicated in people with Hypoglycemia.
• Basalgar is contraindicated in people with a history of hypersensitivity to glargine or any inactive ingredients found in Basaglar KwikPen.

If you forget to take your dose of Basaglar KwikPen, inject it as soon as you remember. However, if it’s close to the scheduled time for your next dose, skip the missed one and proceed with your usual dosing schedule. If you’re uncertain about what to do after missing a dose, consult your healthcare professional, doctor or pharmacist. Do not take more than one dose of Basaglar in a day unless advised by your doctor. To help you remember your Basaglar dose on time, consider setting a reminder, such as using an app or an alarm on your phone.

[Note: If you have missed a medication dose and are unsure when to take the next one, immediately consult your doctor or pharmacist.]

Insulin overdose can cause hypoglycemia. Symptoms may include dizziness, confusion, numbness, muscle weakness, seizure or passing out. Call 911 or head to the nearest emergency room if your symptoms are adverse.

[Note: If you consumed more than the recommended dose, get medical help immediately or call the Poison Help line at 1-800-222-1222.]

There are several guidelines to consider when you buy Basaglar KwikPen online. This includes:

• If you store it in the refrigerator, you can use it till the expiration date.
• If you keep it at room temperature, use it within 28 days.
• Keep it at room temperature and use it within 28 days of opening.
• Do not use the medicine if it appears cloudy, has particles, or has changed colors. Call your pharmacist to get a new medicine.
• Do not store the injection pen with the needle on it.
• Do not reuse the syringe or needle. Dispose of it safely after use in a sharps disposal container and follow the state or local laws for disposal.

[Note: Discuss with your healthcare professional the proper disposal of unused medicine and any questions you may have regarding its storage.]

Basaglar KwikPen may interact with various medications. Inform your healthcare provider about all current medications, including:

• Sulfonylureas (e.g., Glipizide): When used with Basaglar KwikPen, sulfonylureas can increase the risk of hypoglycemia (low blood sugar). This combination requires close monitoring of blood glucose levels to avoid potentially dangerous drops in blood sugar.
• Biguanides (e.g., Metformin): Combining Basaglar KwikPen with Metformin may enhance the glucose-lowering effect, which could increase the risk of hypoglycemia. Regular monitoring and dose adjustments may be necessary to maintain stable blood sugar levels.
• Beta-blockers (e.g., Atenolol): Beta-blockers can mask the symptoms of hypoglycemia, such as rapid heartbeat, when used with Basaglar KwikPen. This may make it harder to detect and treat low blood sugar levels early, requiring more vigilant blood glucose monitoring.
• Thiazolidinediones (e.g., Rosiglitazone): The combination of Basaglar KwikPen with thiazolidinediones may increase the risk of fluid retention and heart failure. Patients must be monitored for symptoms of worsening heart failure, and dosage adjustments may be necessary.
• ACE Inhibitors (e.g., Lisinopril): ACE inhibitors can enhance the blood glucose-lowering effects of Basaglar KwikPen, which may increase the risk of hypoglycemia. Careful monitoring and possible dose adjustments of insulin or ACE inhibitors may be required.
• Corticosteroids (e.g., Prednisone): Corticosteroids can counteract the blood glucose-lowering effects of Basaglar KwikPen, leading to hyperglycemia (high blood sugar). Patients on corticosteroids may require increased doses of insulin to manage their blood sugar levels effectively.
• Monoamine Oxidase Inhibitors (MAOIs, e.g., Phenelzine): MAOIs can potentiate the hypoglycemic effect of Basaglar KwikPen, leading to an increased risk of severe low blood sugar. Close monitoring of glucose levels in blood is essential when these medications are used together.
• Olanzapine: Olanzapine may elevate blood glucose levels, potentially reducing the effectiveness of Basaglar KwikPen. Patients using olanzapine may require higher insulin doses to maintain glycemic control.
• Growth Hormone: Growth hormone can antagonize the effects of Basaglar KwikPen by increasing insulin resistance, which may lead to higher blood glucose levels. Dose adjustments and careful monitoring of blood sugar levels may be necessary.
• Thyroid Hormones (e.g., Levothyroxine): Thyroid hormones can affect glucose metabolism, potentially leading to fluctuations in blood sugar levels. When used with Basaglar KwikPen, monitoring and dosage adjustments may be required to ensure proper blood glucose control.

[Note: This isn’t a complete list, and there could be other drugs that interact with Basaglar KwikPen. Tell your doctor about any prescription, over-the-counter medicines, and herbal products you’re taking.]

While it is an effective treatment option, some patients may seek alternatives due to personal preferences, cost considerations, or specific medical needs. Below are some alternatives to Basaglar KwikPen, each with similar functions but potentially different features or formulations:

• Levemir (insulin detemir)
• Tresiba (insulin degludec)
• Toujeo (insulin glargine)
• Novolin N, Humulin N (insulin NPH)
• Novolin R, Humulin R (insulin regular human)
• Humalog, Admelog (insulin lispro)
• Apidra (insulin glulisine)
• NovoLog, Fiasp (insulin aspart)
• Xultophy (liraglutide and insulin degludec)
• Adlyxin (lixisenatide)
• Soliqua (insulin glargine)
• Victoza (liraglutide)
• Saxenda (liraglutide)
• Invokana (canagliflozin)
• Trulicity (dulaglutide)
• Ozempic (semaglutide)
• Symlin
• Byetta

[Note: Your doctor will choose what’s best for you. Only use these alternative medications after consulting your healthcare provider. Taking them by yourself may cause serious side effects.

U.S. patients seeking to reduce the cost of Basaglar KwikPen may explore purchasing from Canadian online pharmacies like Polar Bear Meds, which offer more affordable options. Polar Bear Meds provides significant savings on Basaglar KwikPen, with direct shipping from Canada to the U.S. New customers can enjoy a 10% discount on their first order by using the promo code ‘WELCOMEPB10.’ Additionally, by joining our referral program, U.S. customers can earn extra coupons, further lowering the cost and improving access to Basaglar KwikPen.

AtPolarBearMeds.com, we assure you the most affordable price to buy Basaglar KwikPen from Canada. Rest easy knowing that your order will be dispatched from a reputable Licensed Canada Pharmacy Online, adhering to the highest standards of quality and authenticity. Our discounted medications are shipped directly from Canada to your doorstep, ensuring a swift and secure delivery experience. To conveniently access Basaglar KwikPen at a substantial cost, call us at1-888-779-2193toll-free.